MICHELLE WALLACE: Open Payments
NPI 1699804641 · CINCINNATI, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$399 in 19 payments from 8 companies in 2025. Trend: 2023 $256 · 2024 $662 · 2025 $399
Food & beverage: $399
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 7 | $147 |
| Novo Nordisk Inc | 5 | $94 |
| MAYNE PHARMA COMMERCIAL LLC | 2 | $46 |
| Hologic Sales and Service, LLC | 1 | $31 |
| Sage Therapeutics, LLC | 1 | $24 |
| MILLICENT US INC | 1 | $23 |
| Lilly USA, LLC | 1 | $18 |
| SHIELD THERAPEUTICS INC | 1 | $16 |
Products named: Veozah, Wegovy, MYOSURE TISSUE REMOVAL DEVICE, ZURZUVAE, INTRAROSA, ZEPBOUND, ACCRUFER.
Industry payments across OH — which companies pay providers there.
